Human Neuroblast differentiation-associated protein AHNAK 2580-2588, SMPDFDLHL
Description
About Human Neuroblast differentiation-associated protein AHNAK 2580-2588, SMPDFDLHL
The Human Neuroblast differentiation-associated protein AHNAK Peptide (IEDB: 128111) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Neuroblast differentiation-associated protein AHNAK Peptide, H-SMPDFDLHL-OH (Uniprot: Q09666 aa: 2580-2588) from JPT is produced under strict quality control and quality management.
Human Neuroblast differentiation-associated protein AHNAK 2580-2588, SMPDFDLHL - Specifications
- Peptide sequence: H-SMPDFDLHL-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Melanoma
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Neuroblast differentiation-associated protein AHNAK 2580-2588, SMPDFDLHL
References:
Read References with JPT’s Antigen Peptides
Human Neuroblast differentiation-associated protein AHNAK 2580-2588, SMPDFDLHL has been described in:
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes., J Clin Invest, 2015 (PMID: 26389673)
HLA class I molecules reflect an altered host proteome after influenza virus infection., Hum Immunol, 2010 (PMID: 19748539)
Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy., Oncoimmunology, 2021 (PMID: 33537173)
Documentation
Documentation for Human Neuroblast differentiation-associated protein AHNAK 2580-2588, SMPDFDLHL
Properties
Properties of Human Neuroblast differentiation-associated protein AHNAK 2580-2588, SMPDFDLHL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Melanoma |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Neuroblast differentiation-associated protein AHNAK |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Neuroblast differentiation-associated protein AHNAK 2580-2588, SMPDFDLHL
Information | Values |
---|---|
Sequence: | H-SMPDFDLHL-OH |
Specifications: | 9mer peptide as TFA salt |